DDSQInnovator Equity Dual Directional 5 Buffer ETF
Seeks to provide capital appreciation by participating in positive returns of the Underlying ETF and buffered returns against losses less than 15% over the Outcome Period.
By Innovator ETFs · Launched 2025
0.79%
#4,215 of 5,861 · expensive
$61M
#3,436 of 5,861 · mid-size
—
8 months
#5,050 of 5,861 · young
Performance
Total-return NAV · USDTotal-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundWhat it actually holds
By weightAsset allocation
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsWorst peak-to-trough loss
Needs 3+ years of history
Needs 3+ years of history
Listing
- Exchange
- Cboe BZX
Full fund details
- Objective
- Seeks to provide capital appreciation by participating in positive returns of the Underlying ETF and buffered returns against losses less than 15% over the Outcome Period.
- Strategy
- Invests primarily in investments providing exposure to the Underlying ETF, aiming for capital appreciation and buffered returns. Seeks to replicate the Underlying ETF's performance over the Outcome Period, providing positive returns regardless of the Underlying ETF's price movement, subject to limitations. If the Underlying ETF appreciates, the Fund provides positive performance limited by the Upside Cap (expected 9.56%-11.06% before fees). If the Underlying ETF decreases by ≤15%, the Fund matches losses up to 15% as Inverse Performance.
- Inception date
- December 31, 2025
- Fund family
- Innovator ETFs
Similar funds
Same asset class, closest by strategy & exposureOur take
Structural notes on how this fund behaves. Read our guide on the 6 warning signs.
You can build this cheaper yourself
Defined-outcome funds cap your gains (often 8% to 20%) in exchange for cushioning losses by 9% to 30%, priced with options. The fee runs about 0.70% or more, against 0.03% to 0.10% for a plain index fund. For most investors, a simple stock-and-bond mix gives similar protection for far less.
Sources: Morningstar, 'Buffer Funds Are on the Rise, but They May Not Make Sense for Most Investors' (2025)
Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More
What's next?
You've looked at DDSQ. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-04